Acetryptine
≈ 2 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Acetryptine (INN; developmental code W-2965-A; also known as 5-acetyltryptamine or 5-AT ) is a drug described as an antihypertensive agent which was never marketed. Structurally, acetryptine is a substituted tryptamine, and is closely related to other substituted tryptamines like serotonin (5-hydroxytryptamine). It was developed in the early 1960s. The binding of acetryptine to serotonin receptors does not seem to have been well-investigated, although it was assessed at the 5-HT 1A and 5-HT 1D receptors and found to bind to them with high affinity. The drug may also act as a monoamine oxidase inhibitor (MAOI); specifically, as an inhibitor of MAO-A.
Acetryptine (INN; developmental code W-2965-A; also known as 5-acetyltryptamine or 5-AT ) is a drug described as an antihypertensive agent which was never marketed. Structurally, acetryptine is a substituted tryptamine, and is closely related to other substituted tryptamines like serotonin (5-hydroxytryptamine). It was developed in the early 1960s. The binding of acetryptine to serotonin receptors does not seem to have been well-investigated, although it was assessed at the 5-HT 1A and 5-HT 1D receptors and found to bind to them with high affinity. The drug may also act as a monoamine oxidase inhibitor (MAOI); specifically, as an inhibitor of MAO-A. ==See also== 5-Benzyloxytryptamine 5-Carboxamidotryptamine 5-Ethoxy-DMT 5-Methoxytryptamine 5-Methyltryptamine 5-(Nonyloxy)tryptamine Azepindole Indorenate Metralindole Pargyline Pirlindole Sumatriptan Tetrindole ==References==
Text derived from https://en.wikipedia.org/w/index.php?oldid=1324086402 under CC BY-SA 4.0; modifications have been made.